HTHTUp +8.9%H World
Why H World (HTHT) Stock Rose 8.9% Today
H World (HTHT) rose 8.9% after the hotel group reported third quarter results and raised its 2026 revenue growth forecast to 9% to 10%.
Movers
Monday
Latest trading day covered
H World
Every big move we have covered on H World, newest first. Each story gives the answer first and links to the filings and releases behind it.
Last covered move
Close that day$54.88
Figures are from the day of the story, not live quotes.
Why it moved that dayNewest first. Moves and closes are for the day each story covers.
HTHTUp +8.9%H World
H World (HTHT) rose 8.9% after the hotel group reported third quarter results and raised its 2026 revenue growth forecast to 9% to 10%.
SMMT CGON HTHT TSN
Summit Therapeutics fell 16.5% after an FDA Complete Response Letter, and CG Oncology rose 14.0% after trial results. H World and Tyson Foods rose.
H World Group Ltd filings with the SEC from the last 180 days, newest first. We wrote about one of them.
Filings come straight from the SEC's EDGAR database and are listed automatically. They are not written or checked by us. Fetched .
All 22 filings, including insider trade reports. Insider reports filed on the same day are grouped into one row.
Notice of planned insider sale (amended)
144/ANotice of planned insider sale
Form 144Large shareholder report
SCHEDULE 13GReport from a foreign company
6-KLarge shareholder report
SCHEDULE 13GInsider trade report
Form 4Report from a foreign company
6-KReport from a foreign company
6-KReport from a foreign company
6-KReport from a foreign company
6-KInsider trade report
Form 4Insider trade reports (3)
Form 4Report from a foreign company
6-KReport from a foreign company
6-KNew insider ownership report
Form 3Report from a foreign company
6-KInsider trade report
Form 4Insider trade report
Form 4Report from a foreign company
6-KInsider trade report
Form 4Insider trade report
Form 4Showing 10 key filings: company reports, results, annual and quarterly reports, proxies and offerings.
Report from a foreign company
6-KReport from a foreign company
6-KReport from a foreign company
6-KReport from a foreign company
6-KReport from a foreign company
6-KReport from a foreign company
6-KReport from a foreign company
6-KReport from a foreign company
6-KReport from a foreign company
6-KAs registered with the SEC
Other stocks in the same day's coverage
Summit Therapeutics
Summit Therapeutics (SMMT) fell 16.5% after it said the FDA issued a Complete Response Letter on its application for ivonescimab in lung cancer.
Close $11.82
CG Oncology
CG Oncology (CGON) rose 14.0% after it said its Phase 3 bladder cancer trial PIVOT-006 met its primary endpoint.
Close $84.78
Tyson Foods
Tyson Foods (TSN) rose 8.7% after it reported fiscal fourth quarter results and forecast fiscal 2027 adjusted operating income of $1.7 billion to $2.15 billion.
Close $63.95
These stories explain past price moves using public sources. They are not investment advice. See our disclaimer.